secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001493152-22-029715
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim shareholders approve 5M share increase to equity plan and authorize reverse stock split
--------------------------------------------------------------------------------

- Amendment to 2019 Equity Incentive Plan adding 5,000,000 shares approved by shareholders (21.6M For, 1.1M Against).
- Reverse stock split authorized at ratio between 2:1 and 15:1, with exact ratio determined by board (26.3M For, 1.4M Against).
- All seven director nominees elected: Mulica, Howe, Wang, Steenstra, Cassano, Liu, Principe.
- Moss Adams ratified as independent auditor for FY2022 (27.0M For, 0.6M Against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315222029715/0001493152-22-029715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315222029715/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-029715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer